221 related articles for article (PubMed ID: 31063707)
1. Neuroprotective offerings by agmatine.
Kotagale NR; Taksande BG; Inamdar NN
Neurotoxicology; 2019 Jul; 73():228-245. PubMed ID: 31063707
[TBL] [Abstract][Full Text] [Related]
2. Type-2 cannabinoid receptors in neurodegeneration.
Bisogno T; Oddi S; Piccoli A; Fazio D; Maccarrone M
Pharmacol Res; 2016 Sep; 111():721-730. PubMed ID: 27450295
[TBL] [Abstract][Full Text] [Related]
3. Role of agmatine in neurodegenerative diseases and epilepsy.
Moretti M; Matheus FC; de Oliveira PA; Neis VB; Ben J; Walz R; Rodrigues AL; Prediger RD
Front Biosci (Elite Ed); 2014 Jun; 6(2):341-59. PubMed ID: 24896210
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of agmatine for CNS disorders.
Neis VB; Rosa PB; Olescowicz G; Rodrigues ALS
Neurochem Int; 2017 Sep; 108():318-331. PubMed ID: 28522414
[TBL] [Abstract][Full Text] [Related]
5. Accelerated functional recovery and neuroprotection by agmatine after spinal cord ischemia in rats.
Gilad GM; Gilad VH
Neurosci Lett; 2000 Dec; 296(2-3):97-100. PubMed ID: 11108990
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of agmatine against cell damage caused by glucocorticoids in cultured rat hippocampal neurons.
Zhu MY; Wang WP; Bissette G
Neuroscience; 2006 Sep; 141(4):2019-27. PubMed ID: 16777341
[TBL] [Abstract][Full Text] [Related]
7. Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury.
Kim JH; Yenari MA; Giffard RG; Cho SW; Park KA; Lee JE
Exp Neurol; 2004 Sep; 189(1):122-30. PubMed ID: 15296842
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective Effect of Antioxidants in the Brain.
Lee KH; Cha M; Lee BH
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998277
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective Role of Agmatine in Neurological Diseases.
Xu W; Gao L; Li T; Shao A; Zhang J
Curr Neuropharmacol; 2018; 16(9):1296-1305. PubMed ID: 28786346
[TBL] [Abstract][Full Text] [Related]
10. Ion channels on microglia: therapeutic targets for neuroprotection.
Skaper SD
CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):44-56. PubMed ID: 21143139
[TBL] [Abstract][Full Text] [Related]
11. Agmatine effects on mitochondrial membrane potential and NF-κB activation protect against rotenone-induced cell damage in human neuronal-like SH-SY5Y cells.
Condello S; Currò M; Ferlazzo N; Caccamo D; Satriano J; Ientile R
J Neurochem; 2011 Jan; 116(1):67-75. PubMed ID: 21044082
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the dose-dependent neuroprotective effects of agmatine in experimental spinal cord injury: a prospective randomized and placebo-control trial.
Kotil K; Kuscuoglu U; Kirali M; Uzun H; Akçetin M; Bilge T
J Neurosurg Spine; 2006 May; 4(5):392-9. PubMed ID: 16703907
[TBL] [Abstract][Full Text] [Related]
13. Agmatine improves locomotor function and reduces tissue damage following spinal cord injury.
Yu CG; Marcillo AE; Fairbanks CA; Wilcox GL; Yezierski RP
Neuroreport; 2000 Sep; 11(14):3203-7. PubMed ID: 11043549
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic new insights of flavonols on neurodegenerative diseases.
Tahir MS; Almezgagi M; Zhang Y; Bashir A; Abdullah HM; Gamah M; Wang X; Zhu Q; Shen X; Ma Q; Ali M; Solangi ZA; Malik WS; Zhang W
Biomed Pharmacother; 2021 May; 137():111253. PubMed ID: 33545661
[TBL] [Abstract][Full Text] [Related]
15. Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons.
Wang WP; Iyo AH; Miguel-Hidalgo J; Regunathan S; Zhu MY
Brain Res; 2006 Apr; 1084(1):210-6. PubMed ID: 16546145
[TBL] [Abstract][Full Text] [Related]
16. Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB
Ferrisi R; Ceni C; Bertini S; Macchia M; Manera C; Gado F
Pharmacol Res; 2021 Aug; 170():105607. PubMed ID: 34089867
[TBL] [Abstract][Full Text] [Related]
17. [Neuroprotection in the treatment of multiple sclerosis].
Zipp F; Gold R
Nervenarzt; 2011 Aug; 82(8):973-7. PubMed ID: 21761185
[TBL] [Abstract][Full Text] [Related]
18. Agmatine treatment is neuroprotective in rodent brain injury models.
Gilad GM; Salame K; Rabey JM; Gilad VH
Life Sci; 1996; 58(2):PL 41-6. PubMed ID: 8606618
[TBL] [Abstract][Full Text] [Related]
19. Exogenous agmatine has neuroprotective effects against restraint-induced structural changes in the rat brain.
Zhu MY; Wang WP; Cai ZW; Regunathan S; Ordway G
Eur J Neurosci; 2008 Mar; 27(6):1320-32. PubMed ID: 18364017
[TBL] [Abstract][Full Text] [Related]
20. Effect of agmatine against cell death induced by NMDA and glutamate in neurons and PC12 cells.
Zhu MY; Piletz JE; Halaris A; Regunathan S
Cell Mol Neurobiol; 2003 Oct; 23(4-5):865-72. PubMed ID: 14514037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
